Personalis, Inc. (PSNL)
17.08
-1.30
(-7.07%)
USD |
NASDAQ |
Aug 24, 16:00
17.08
0.00 (0.00%)
After-Hours: 20:00
Personalis Shareholders Equity (Quarterly) : 235.16M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 235.16M |
| March 31, 2026 | 254.76M |
| December 31, 2025 | 261.18M |
| September 30, 2025 | 171.42M |
| June 30, 2025 | 190.83M |
| March 31, 2025 | 207.34M |
| December 31, 2024 | 202.96M |
| September 30, 2024 | 166.76M |
| June 30, 2024 | 112.27M |
| March 31, 2024 | 120.69M |
| December 31, 2023 | 129.44M |
| September 30, 2023 | 151.21M |
| June 30, 2023 | 176.09M |
| March 31, 2023 | 193.63M |
| December 31, 2022 | 218.14M |
| September 30, 2022 | 242.40M |
| Date | Value |
|---|---|
| June 30, 2022 | 264.63M |
| March 31, 2022 | 286.72M |
| December 31, 2021 | 310.30M |
| September 30, 2021 | 325.30M |
| June 30, 2021 | 338.75M |
| March 31, 2021 | 348.42M |
| December 31, 2020 | 194.94M |
| September 30, 2020 | 203.54M |
| June 30, 2020 | 93.12M |
| March 31, 2020 | 99.20M |
| December 31, 2019 | 106.69M |
| September 30, 2019 | 111.39M |
| June 30, 2019 | 117.02M |
| March 31, 2019 | -21.12M |
| December 31, 2018 | -16.98M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tempus AI, Inc. | 444.93M |
| 10X Genomics, Inc. | 825.55M |
| Alamar Biosciences, Inc. (California) | 312.86M |
| Adaptive Biotechnologies Corp. | 142.91M |
| Champions Oncology, Inc. | 3.939M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 312.14M |
| Total Liabilities (Quarterly) | 76.97M |
| Debt to Equity Ratio | 0.1616 |
| Current Ratio | 5.242 |
| Net Debt Paydown Yield | 0.10% |